Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
hexachlorophene | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 5.9700 | 1 | 0 |
disperse red 9 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.8000 | 1 | 0 |
1-amino-4-hydroxyanthraquinone | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.1000 | 1 | 0 |
2,4-dihydroxybenzophenone | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
lysergol | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 12.3800 | 1 | 0 |
s-2678 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 1.3200 | 1 | 0 |
diacetylfluorescein | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
coumarin 153 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
methyl fluorone black | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 1.0000 | 1 | 0 |
9-hydroxyphenylfluoron | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 5.2900 | 1 | 0 |
ergocornine | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.6400 | 1 | 0 |
2-butyl-6-(butylamino)-1h-benzo(de)isoquinoline-1,3(2h)-dione | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
paxilline | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.0300 | 1 | 0 |
epiberberine | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
2,3-diaminophenazine | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.4200 | 1 | 0 |
6-amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 4.5300 | 1 | 0 |
1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 8.8200 | 1 | 0 |
2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 14.5500 | 1 | 0 |
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 5.9700 | 1 | 0 |
2-[(1-ethyl-2,5-dimethyl-3-pyrrolyl)methylidene]indene-1,3-dione | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 16.2300 | 1 | 0 |
4,5-dimethylcyclopenta[c]quinolizine-1,2-dicarboxylic acid dimethyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.6100 | 1 | 0 |
1,4,8-trimethyl-12-quinolino[2,3-b]quinolinamine | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 0.9200 | 1 | 0 |
3-amino-2-(4-methoxyphenyl)-7-nitro-1-oxo-4-isoquinolinecarbonitrile | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
1-(3,4-dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.5400 | 1 | 0 |
1-[2,3-bis(2-furanyl)-6-quinoxalinyl]-3-[4-(4-morpholinyl)phenyl]thiourea | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.8600 | 1 | 0 |
4-[[4-(2,3-dimethylphenyl)-1-piperazinyl]methyl]-2,6-dimethoxyphenol | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
9-methoxy-6-[(4-methoxyphenyl)methyl]indolo[3,2-b]quinoxaline | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.2700 | 1 | 0 |
[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]-[(1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]cyanamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
2-[2-[[2-[(3-carbamoyl-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)amino]-2-oxoethyl]thio]-4-thiazolyl]acetic acid ethyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
2-(2-cyanophenoxy)acetic acid [2-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-oxoethyl] ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
4-[3-(2,5-dimethyl-1-pyrrolyl)-4-(1-pyrrolidinyl)phenyl]sulfonylmorpholine | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
2-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 31.1400 | 1 | 0 |
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 6.6100 | 1 | 0 |
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
LSM-16248 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.7300 | 1 | 0 |
4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
7-[[[1-(3-methylphenyl)-2-benzimidazolyl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.7900 | 1 | 0 |
2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 8.4800 | 1 | 0 |
N-[(2-hydroxy-1-naphthalenyl)-(4-methylphenyl)methyl]cyclohexanecarboxamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
N-(2-furanylmethyl)-1-[2-(2-hydroxyethoxy)ethyl]-2-imino-10-methyl-5-oxo-3-dipyrido[3,4-c-1',2'-f]pyrimidinecarboxamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.6100 | 1 | 0 |
N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
LSM-16826 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 6.0500 | 1 | 0 |
methysergide maleate | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
3-(dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 54.0000 | 1 | 0 |
LSM-6455 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 8.5200 | 1 | 0 |
N-[3-[(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-1-isoindolylidene]-2-thiophenecarboxamide | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 3.1900 | 1 | 0 |